LU76367A1 - - Google Patents
Info
- Publication number
- LU76367A1 LU76367A1 LU76367A LU76367A LU76367A1 LU 76367 A1 LU76367 A1 LU 76367A1 LU 76367 A LU76367 A LU 76367A LU 76367 A LU76367 A LU 76367A LU 76367 A1 LU76367 A1 LU 76367A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752556326 DE2556326A1 (de) | 1975-12-13 | 1975-12-13 | Neue pyrrolidone und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU76367A1 true LU76367A1 (da) | 1977-06-28 |
Family
ID=5964379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU76367A LU76367A1 (da) | 1975-12-13 | 1976-12-10 |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS5273865A (da) |
| AU (1) | AU2047376A (da) |
| BE (1) | BE849346R (da) |
| CA (1) | CA1072108A (da) |
| DE (1) | DE2556326A1 (da) |
| DK (1) | DK554776A (da) |
| FR (1) | FR2334352A2 (da) |
| GB (1) | GB1569982A (da) |
| IL (1) | IL51090A0 (da) |
| LU (1) | LU76367A1 (da) |
| NL (1) | NL7613643A (da) |
| SE (1) | SE7613948L (da) |
| ZA (1) | ZA767379B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4772601A (en) * | 1988-01-25 | 1988-09-20 | Hoechst-Roussel Pharmaceuticals, Inc. | 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use |
| DK1408961T3 (da) | 2001-07-16 | 2007-11-05 | Hoffmann La Roche | 2 pyrrolidon-derivater som prostanoide agonister |
| KR20040015364A (ko) | 2001-07-16 | 2004-02-18 | 에프. 호프만-라 로슈 아게 | Ｅｐ4 수용체 작용물질로서의 프로스타글란딘 유사체 |
| BR0211364A (pt) | 2001-07-23 | 2004-07-13 | Ono Pharmaceutical Co | Composição farmacêutica para tratamento de doenças associadas com redução na massa óssea compreendendo o agonista ep4 como componente ativo |
| NZ535024A (en) | 2002-03-05 | 2006-10-27 | Ono Pharmaceutical Co | 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
| WO2004063158A1 (en) | 2003-01-10 | 2004-07-29 | F.Hoffmann-La Roche Ag | 2-piperidone derivatives as prostaglandin agonists |
| US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
-
1975
- 1975-12-13 DE DE19752556326 patent/DE2556326A1/de active Pending
-
1976
- 1976-12-08 NL NL7613643A patent/NL7613643A/xx not_active Application Discontinuation
- 1976-12-10 IL IL51090A patent/IL51090A0/xx unknown
- 1976-12-10 ZA ZA767379A patent/ZA767379B/xx unknown
- 1976-12-10 AU AU20473/76A patent/AU2047376A/en not_active Expired
- 1976-12-10 SE SE7613948A patent/SE7613948L/xx unknown
- 1976-12-10 LU LU76367A patent/LU76367A1/xx unknown
- 1976-12-10 DK DK554776A patent/DK554776A/da unknown
- 1976-12-13 BE BE173206A patent/BE849346R/xx active
- 1976-12-13 CA CA267,691A patent/CA1072108A/en not_active Expired
- 1976-12-13 JP JP51148823A patent/JPS5273865A/ja active Pending
- 1976-12-13 FR FR7637469A patent/FR2334352A2/fr active Granted
- 1976-12-13 GB GB51912/76A patent/GB1569982A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2334352A2 (fr) | 1977-07-08 |
| NL7613643A (nl) | 1977-06-15 |
| DK554776A (da) | 1977-06-14 |
| SE7613948L (sv) | 1977-06-14 |
| JPS5273865A (en) | 1977-06-21 |
| FR2334352B2 (da) | 1978-12-08 |
| DE2556326A1 (de) | 1977-06-23 |
| IL51090A0 (en) | 1977-02-28 |
| CA1072108A (en) | 1980-02-19 |
| AU2047376A (en) | 1978-06-15 |
| BE849346R (fr) | 1977-06-13 |
| ZA767379B (en) | 1977-11-30 |
| GB1569982A (en) | 1980-06-25 |